Health
The President’s Treatment – American Council on Science and Health
It was announced that President Trump was started on an investigational drug as part of his treatment for COVID-19, Regeneron’s Regn-COV2, a combinational of mo…
The drug is currently in a series of Phase 1 blending into Phase 2 studies. There are no published reports in the literature, and all my information comes from Regeneron’s statements to investors two or three days before it was given to the President.
The drug is a combination of two designer antibodies that attach and “disable” the spike proteins associated specifically with COVID-19, resulting in a reduction of viral load, and at least in “non-human” primates, less lung damage. The underlyin…
-
Noosa News17 hours agoMan allegedly killed at teenage house party identified as co-founder of Universal Store
-
Noosa News22 hours agoFather found stabbed dead upstairs at teenagers’ Brisbane house party
-
Noosa News23 hours agoSA ban on plastic produce stickers on hold as growers struggle with costs
-
General22 hours agoJim Chalmers will have to juggle competing demands to secure tax reform